RESERPINE AND BREAST CANCER
- 1 September 1974
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 304 (7882) , 669-671
- https://doi.org/10.1016/s0140-6736(74)93257-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- RESERPINE USE IN RELATION TO BREAST CANCERThe Lancet, 1974
- RETROSPECTIVE STUDY OF THE ASSOCIATION BETWEEN USE OF RAUWOLFIA DERIVATIVES AND BREAST CANCER IN ENGLISH WOMENThe Lancet, 1974
- HYPOTHALAMIC-PITUITARY-PROLACTIN AXIS IN BREAST CANCERThe Lancet, 1974
- Etiology of Human Breast Cancer: A Review2JNCI Journal of the National Cancer Institute, 1973
- PROLACTIN DEPENDENCE IN HUMAN BREAST CANCERSThe Lancet, 1972
- Prolactin Secretion in Patients Treated With Various DrugsArchives of internal medicine (1960), 1972
- Effects of reserpine on development of 7,12-dimethylbenzanthracene induced mammary tumors in female ratsCellular and Molecular Life Sciences, 1970
- Estimation of Relative Risk from Individually Matched SeriesBiometrics, 1970
- Individual Matching with Multiple Controls in the Case of All-or-None ResponsesPublished by JSTOR ,1969